LAMP May Light the Way to New Generation of Vaccines

More than half of all Americans test positive for allergies, according to the American Academy of Allergy, Asthma and Immunology. That’s a lot of sneezing, itchy eyes, and scratchy throats for one nation. Allergy vaccines help many patients cope with their symptoms, but the conventional method of...

Implantable Surgical Mesh, Fascial Defects, Hernia Repair, Pelvic Wall Reconstruction.

Surgery, Urology.Company develops biological meshes for the repair of fascial defects, such as hernias. In fascial defects there is a break in the wall of the body cavity, and biological meshes serve to provide structural support and repair. The company has developed several biological meshes for treatment...

Synthetic Tissue Adhesives and Sealants, Tissue Repair.

Orthopedics, Surgery.Company provides a portfolio of surgical adhesives and coating products derived from synthetic biomaterials designed to enhance natural tissue repair processes while reducing post-surgical complications (e.g., biofilm formation and adhesions). The company received an NIH grant in...

Patient-Derived Stem Cell Therapies, Spinal Cord Injury, Multiple Sclerosis, Parkinson’s Disease.

Regenerative Medicine, Neurology. Company has developed patient-derived, adult stem cell based therapies for the treatment of neurological damage from spinal cord injury, thereby circumventing the use of generic or embryonic stem cells. Through a standard ENT procedure a patients own stem cells are harvested...

Stem Cell Therapies, Age Related Macular Degeneration, Parkinson’s Disease, Multiple Sclerosis.

Regenerative Medicine, Neurology, Ophthalmology. Company develops stem cell therapies for degenerative retinal and neurological diseases. Its lead product facilitates retinal pigmented epithelial cell transplantation to treat age related macular degeneration, which is the leading cause of visual impairment...

Antibody-Based Therapies, T-Cell Mediated Diseases.

Immunology, Oncology, Diabetes. Company provides a highly specific antibody-based T-cell antagonist with broad application potential in T-cell mediated conditions, including transplant rejection, type 1 diabetes and pediatric acute lymphoblastic leukemia. Over 100 million people worldwide suffer from T-cell...

Antibody-Based Therapies, Substance Abuse.

Neurology, Immunology.Company develops monoclonal antibody (mAb) therapies for the treatment of substance abuse, among other conditions. mAb medications can bind to toxic and addictive compounds in the bloodstream and restrict their transport into the brain, thereby counteracting their ‘rewarding...

Bacteriophage Prevention of Antibiotic Resistance.

Diagnostics, Infectious Diseases.Company has developed patent-pending bacteriophages designed to increase the efficacy and extend the lifetime of antibiotics. Bacteriophages serve as biological agents that target bacteria and compromise their viability, and the company’s technology specifically inhibits...